Videos and Recordings

Videos and Recordings

Bloomberg Radio Interview | February 07, 2019
In a conversation with Tom Moroney and Peter Barnes that highlights the power of the protein, Quanterix CEO Kevin Hrusovsky explains how Simoa is powering advances in research, specifically for the detection and treatment of Alzheimer’s and other neurodegenerative diseases.  
WCVB News Boston | February 06, 2019
WCVB's Emily Reimer explores Quanterix' next generation Simoa planar array technology.
NECN | January 25, 2019
An overview of Quanterix’ story, detailing our groundbreaking Simoa technology, the process of measuring biomarkers to detect and advance the treatment of disease, as well as the real world applications of how our technology is impacting how health care is practiced.
January 09, 2019
Quanterix CEO Kevin Hrusovsky presents at the 37th Annual J.P Morgan Healthcare Conference Access the Webcast and Q&A
December 12, 2018
Quanterix is proud to have sponsored the 2018 Powering Precision Health Summit in Amsterdam on December 12, where industry leaders joined for a day of discussion on the latest in medical research and exciting new opportunities to change the approach to healthcare. In this video, PPH Founder, Kevi
Take a virtual tour!
Learn about the next-generation Simoa biomarker detection technology that enables researchers to multiplex up to 10 analytes with unprecedented sensitivity.
Early Diagnosis Through Predictive Biomarkers, NonInvasive Testing
In an excerpt from a panel discussion which took place at MedCity CONVERGE on July 11, 2018, Quanterix Chairman and CEO Kevin Hrusovsky joins other key innovators to discuss game-changing biotech advancements and the future of healthcare.
President, CEO & Chairman of Quanterix
We're passionate about the work we do and believe we can transform today’s sick care into tomorrow’s precision healthcare.
Take a Virtual Tour
Quanterix' proprietary Simoa Bead Technology is based on the isolation of individual immunocomplexes on paramagnetic beads using standard ELISA reagents.